Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Walvax Initiates Phase I Trial of Lyophilized Shingles mRNA Vaccine – First‑in‑Class Herpes Zoster Candidate Co‑Developed with Fudan University and RQ Biotech
CompanyDrug

Walvax Initiates Phase I Trial of Lyophilized Shingles mRNA Vaccine – First‑in‑Class Herpes Zoster Candidate Co‑Developed with Fudan University and RQ Biotech

Walvax Biotechnology Co., Ltd. (SHE: 300142) announced the official initiation of a Phase I clinical trial of its lyophilized herpes zoster (shingles) mRNA vaccine, co‑developed with Fudan University and RQ…

Keymed Biosciences' Stapokibart Wins Fourth NMPA Indication – Adolescent Atopic Dermatitis Approval as Kangyueda Revenue Surges 227%

Keymed Biosciences’ Stapokibart Wins Fourth NMPA Indication – Adolescent Atopic Dermatitis Approval as Kangyueda Revenue Surges 227%

ChemPartner and BioBAY Open Arsenal Innovation Center in Massachusetts – Bridging Suzhou and Boston Life Science Ecosystems

ChemPartner and BioBAY Open Arsenal Innovation Center in Massachusetts – Bridging Suzhou and Boston Life Science Ecosystems

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Biocytogen and Tracon Pharmaceuticals Gain FDA IND Approval for Sarcoma Trial

CompanyDrug

ImmuneOnco’s IMM40H Receives NMPA Clinical Trial Approval for CD70 Antibody

CompanyDrug

Junshi Biosciences’ TAB009/JS009 and JS110 Advance in Cancer Trials

CompanyDrug

Junshi Biosciences Gets NMPA Go-Ahead for TAB009/JS009 Cancer Study

CompanyDrug

Ranok Therapeutics Doses First Patient in RNK05047 Study for BRD4-Targeted Cancers

CompanyDrug

SinoMab Bioscience’s SN1011 Gets NMPA Nod for NMOSD Trial

CompanyDrug

Mabwell Bioscience Receives NMPA Approval for 6MW3511 Clinical Trial in Solid Tumors

CompanyDrug

Bio-Thera Solutions Receives NMPA Approval for BAT8008 Clinical Trial in Solid Tumors

Show More